Skip to main content
Journal cover image

Assessing oral beta-blocker therapy after percutaneous coronary intervention for ST-segment elevation myocardial infarction: the role of observational data.

Publication ,  Journal Article
Granger, CB; Rao, MP
Published in: JACC Cardiovasc Interv
June 2014

Duke Scholars

Published In

JACC Cardiovasc Interv

DOI

EISSN

1876-7605

Publication Date

June 2014

Volume

7

Issue

6

Start / End Page

602 / 603

Location

United States

Related Subject Headings

  • Secondary Prevention
  • Registries
  • Percutaneous Coronary Intervention
  • Patient Discharge
  • Myocardial Infarction
  • Male
  • Humans
  • Female
  • Cardiovascular System & Hematology
  • Adrenergic beta-Antagonists
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Granger, C. B., & Rao, M. P. (2014). Assessing oral beta-blocker therapy after percutaneous coronary intervention for ST-segment elevation myocardial infarction: the role of observational data. JACC Cardiovasc Interv, 7(6), 602–603. https://doi.org/10.1016/j.jcin.2014.04.002
Granger, Christopher B., and Meena P. Rao. “Assessing oral beta-blocker therapy after percutaneous coronary intervention for ST-segment elevation myocardial infarction: the role of observational data.JACC Cardiovasc Interv 7, no. 6 (June 2014): 602–3. https://doi.org/10.1016/j.jcin.2014.04.002.
Granger, Christopher B., and Meena P. Rao. “Assessing oral beta-blocker therapy after percutaneous coronary intervention for ST-segment elevation myocardial infarction: the role of observational data.JACC Cardiovasc Interv, vol. 7, no. 6, June 2014, pp. 602–03. Pubmed, doi:10.1016/j.jcin.2014.04.002.
Journal cover image

Published In

JACC Cardiovasc Interv

DOI

EISSN

1876-7605

Publication Date

June 2014

Volume

7

Issue

6

Start / End Page

602 / 603

Location

United States

Related Subject Headings

  • Secondary Prevention
  • Registries
  • Percutaneous Coronary Intervention
  • Patient Discharge
  • Myocardial Infarction
  • Male
  • Humans
  • Female
  • Cardiovascular System & Hematology
  • Adrenergic beta-Antagonists